[
    [
        {
            "time": "2020-06-23",
            "original_text": "智飞生物新冠疫苗获临床试验批件！成史上第三只百元渝股，总市值达1648亿元",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "临床试验",
                    "批件",
                    "百元渝股",
                    "总市值"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物技术"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物新冠疫苗获临床试验批件！成史上第三只百元渝股，总市值达1648亿元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-06-23",
            "original_text": "超级大单：千亿医药巨头突发利好，5亿资金却大出逃",
            "features": {
                "keywords": [
                    "超级大单",
                    "医药巨头",
                    "突发利好",
                    "资金出逃"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "超级大单：千亿医药巨头突发利好，5亿资金却大出逃",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-23",
            "original_text": "智飞生物大涨，云游戏和软件股大爆发，A股从来不缺牛股，频出牛股的板块都有一个核心特征",
            "features": {
                "keywords": [
                    "智飞生物",
                    "大涨",
                    "云游戏",
                    "软件股",
                    "牛股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物大涨，云游戏和软件股大爆发，A股从来不缺牛股，频出牛股的板块都有一个核心特征",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-06-23",
            "original_text": "快讯：智飞生物涨停 报于108.01元",
            "features": {
                "keywords": [
                    "智飞生物",
                    "涨停",
                    "股价"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "快讯：智飞生物涨停 报于108.01元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-06-23",
            "original_text": "新冠疫苗获临床试验批件 智飞生物午后直拉涨8%",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "临床试验",
                    "智飞生物",
                    "涨8%"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "新冠疫苗获临床试验批件 智飞生物午后直拉涨8%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-06-23",
            "original_text": "特大利好！子公司合作研发新冠疫苗获临床批件 智飞生物股价午后股价“腾飞”",
            "features": {
                "keywords": [
                    "特大利好",
                    "子公司",
                    "新冠疫苗",
                    "临床批件",
                    "智飞生物",
                    "股价腾飞"
                ],
                "sentiment_score": 0.98,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "特大利好！子公司合作研发新冠疫苗获临床批件 智飞生物股价午后股价“腾飞”",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        }
    ]
]